PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: iCube (iCube+)

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Prosol S.p.A. at Food Ingredients Europe & Natural Ingredients 2015 in Paris - Prosol S.p.A. will attend Fi Europe & Ni on the 1-3th December 2015. A great opportunity to stay tuned on the latest news about industry trends and the changing of nutraceuticals market - Prosol-spa.it
Prosol S.p.A. at Food Ingredients Europe & Natural Ingredients 2015 in Paris

 

NewswireToday - /newswire/ - Catania, Italy, 2015/10/22 - Prosol S.p.A. will attend Fi Europe & Ni on the 1-3th December 2015. A great opportunity to stay tuned on the latest news about industry trends and the changing of nutraceuticals market - Prosol-spa.it.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Prosol S.p.A., the Italian biotechnology company based in Madone, will be present at Food Ingredients Europe & Natural Ingredients 2015 on 1-3rd December in Paris, France. The event brings together the world's leading ingredients suppliers, distributors and buyers from the food and beverage industry and is considered as one of the top 10 most important events of the Food & Beverage industry, with exhibitors from all around the world. The event would be a great opportunity to stay tuned on the latest news about industry trends and the changing of nutraceuticals market. The Trade Show is organized biennially and Prosol has already successfully participated at the 2009 and 2011 editions: this year Prosol is again ready to meet Technical and R&D Managers in order to share its vision and start mutually useful relationships at FIE.
During Fi Europe & Ni 2015 Prosol’s experts will be able to help you and your business finding the best ingredients designed to cover your customer needs, and selecting the most innovative solutions in key areas like immune health, natural ingredients and salt reduction, baby food, supplements & nutraceuticals.
Prosol selects ingredients for the improvement of the functional and nutritional values of foods, offering the following advantages: immune modulation improvement in infant formula and dietary supplements (with Yeasts’ Nucleic Acids and Nucleotides); improvement in taste profile, monosodium glutamate replacement and salt reduction (with natural flavour enhancers);.

PROSOL: COMPANY PROFILE
Prosol (prosol-spa.it) develops innovative nutritional ingredients for the food and the nutraceutical industry. Prosol is a reputed leader in the production of Yeast's Ribonucleic Acid (RNA) and derivatives rich in natural 5'-nucleotides effective in immunity and flavour enhancing. Prosol has an in-house developed technology and its production is totally sustainable, without the use of chemical solvents. Prosol selects and mixes 5'-nucleotides for infant formula. The Company has also gained the ISO, IFS and OHSAS certifications.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: iCube (iCube+)

 
 

Availability: All Metropolitan Area

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Prosol S.p.A. at Food Ingredients Europe & Natural Ingredients 2015 in Paris

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Laura Fassari - iCubePlus.com 
+39 344173304 prosol[.]prosol-spa.it
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any iCube (iCube+) securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From iCube (iCube+) / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

Ipsen Announces Phase 3 CELESTIAL Trial of Cabozantinib Meets Primary Endpoint of Overall Survival
First Patient Treated with Microscopic Beads Pre-loaded with A Targeted Cancer Drug and Visible on CT Scans
BTG Plc Acquires Roxwood Medical
BTG and Mirada Medical Sign Three-Year Software Development Agreement
U.S. FDA Approves New Indication for Ipsen’s Somatuline® Depot (lanreotide) Injection for the Treatment of Carcinoid Syndrome
Genentech Provides Update on First Lampalizumab Phase III Study for Geographic Atrophy, an Advanced Form of Age-Related Macular Degeneration
mProve Health and Greenphire Partner to Deliver a First-of-its-Kind Patient Engagement Solution
FDA Approves Genentech’s Actemra (Tocilizumab) for the Treatment of CAR T Cell-Induced Cytokine Release Syndrome
Greenphire Named to Inc. 5000 for Fifth Consecutive Year
Five Community Health Centers Honored for Innovative Approaches to Medication Therapy Management
FDA Grants Priority Review for Genentech’s Gazyva in Previously Untreated Follicular Lymphoma
ProSci Incorporates Flow Cytometry Screening to Custom Monoclonal Antibody Service
FDA Grants Priority Review to Genentech's Emicizumab for Hemophilia A with Inhibitors
BD Expands Suite of Blood Culture Offerings with New BD BACTEC™ Standard Aerobic & Standard Anaerobic Plastic Bottles
Twist Bioscience Collaborates with Synbio Technologies to Supply Long DNA to Customers

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  La Bella Bakery Artisan Bakery Arizona

Visit  NAKIVO, Inc.





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)